Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

Completed · Phase 3

Conditions studied: General Anxiety Disorder

In brief

To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).

Key facts

Study ID
NCT00233675
Run by
Cephalon
Starts
2003-08-01
Last updated by the study team
2023-04-12

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.